What does Antheia do?
Antheia is a pharmaceutical ingredient manufacturer that uses advanced biosynthesis and fermentation technology to produce key starting materials and active pharmaceutical ingredients, supporting rapid and on-demand production essential for public health.
How much did they raise?
The company raised $56M in a Series C round led by Global Health Investment Corporation, with additional participation from ATHOS KG, Viking Global Investors, Sherpalo Ventures, S-Cubed Capital, In-Q-Tel (IQT), and Civilization Ventures.
What are their plans for the money?
Antheia intends to expand the commercialization of its first product, thebaine, and launch additional products, potentially improving global access to essential medicines and addressing the growing needs of public health.
What have they achieved so far?
Antheia has already developed an innovative biomanufacturing platform that enables rapid, efficient, and agile production of pharmaceutical ingredients, setting the stage for broader market adoption.
